5HT2C receptor agonists and antagonists in animal models of anxiety

By Martin J.R.   Bouml s M.   Jenck F.   Kouml hler C.   Moreau J.-L.   Sleight A.J.   Stadler H.   Wichmann J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 209-209

Elsevier

Access to resources Recommend Favorite

5-HT2C Receptor Agonists as Potential Drugs for the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-05 ,pp. : 885-897

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis, pharmacology and therapeutic potential of 10-methoxypyrazino[1,2-a]indoles, partial agonists at the 5HT 2C receptor

By Bos M.   Jenck F.   Martin J.   Moreau J.   Mutel V.   Sleight A.   Widmer U.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 3, 1997-01 ,pp. : 253-261

Elsevier

Access to resources Recommend Favorite

Antiaversive effects of 5HT 2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats

By Jenck F.   Moreau J.-L.   Berendsen H.H.G.   Boes M.   Broekkamp C.L.E.   Martin J.R.   Wichmann J.   Van Delft A.M.L.  

European Neuropsychopharmacology, Vol. 8, Iss. 3, 1998-08 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

5HT 2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats

By Moreau J.-L.   Bos M.   Jenck F.   Martin J.R.   Mortas P.   Wichmann J.  

European Neuropsychopharmacology, Vol. 6, Iss. 3, 1996-08 ,pp. : 169-175

Elsevier

Access to resources Recommend Favorite